IP Library Granted Patent US 11,484,629
Granted Patent B2
US 11,484,629 · App. 16/567,845 · Granted Nov 1, 2022

Intravascular devices with high tungsten content

Inventors: Hancun Chen (San Ramon, CA); Andrew S. Lee (San Jose, CA)
Assignee: Stryker Corporation
A61L31/022A61L31/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,484,629
App. No.
16/567,845
Granted
Nov 1, 2022
Kind
B2
Abstract

Implantable medical devices, such as embolic devices and blood flow filters are disclosed, the devices being made at least partially out of a platinum-tungsten alloy, wherein a percentage of tungsten in the alloy is equal to or greater than about 10% of the alloy by weight.

Claims (25)

1. An implantable medical device, comprising:

one or more elongate members composed of a platinum-tungsten alloy, wherein the percentage of tungsten in the platinum-tungsten alloy is equal to or greater than about 16% by weight.

2. The device of claim 1 , wherein the one or more elongate members comprise a cut tube.

3. The device of claim 1 , wherein the one or more elongate members comprise a plurality of composite wires, each having at least one layer composed of the platinum-tungsten alloy.

4. The device of claim 1 , wherein the one or more elongate members comprise a plurality of wires or filaments woven in a braided configuration.

5. The device of claim 1 , wherein the percentage of tungsten in the platinum-tungsten alloy is a range from about 16% to about 20% by weight.

6. The device of claim 5 , wherein the percentage of tungsten in the platinum- tungsten alloy is about 16% by weight.

7. The device of claim 6 , wherein the one or more elongate members comprise a wire having an ultimate tensile strength that is approximately 100% greater than an ultimate tensile strength of a substantially identically dimensioned alternative wire composed of an alternative platinum-tungsten alloy having a percentage of tungsten that is about 8% by weight.

8. The device of claim 6 , wherein the one or more elongate members comprise a wire having a Young's modulus that is approximately 40% greater than a Young's modulus of a substantially identically dimensioned alternative wire composed of an alternative platinum- tungsten alloy having a percentage of tungsten that is about 8% by weight.

9. The device of claim 6 , wherein the one or more elongate members comprise a wire having a magnetic susceptibility that is approximately 60% less than a magnetic susceptibility of a substantially identically dimensioned alternative wire composed of an alternative platinum-tungsten alloy having a percentage of tungsten that is about 8% by weight.

10. An implantable medical device, comprising:

a plurality of wires woven in a braided configuration,

wherein at least a subset of wires of the plurality are composed of a platinum-tungsten alloy having a percentage of tungsten in a range from about 16% to about 20% by weight.

11. The device of claim 10 , wherein the wires of the subset comprise composite wires, each including at least one layer composed of the platinum-tungsten alloy.

12. The device of claim 10 , wherein at least some wires of the subset composed of the platinum-tungsten alloy have non-circular cross-sections.

13. The device of claim 12 , wherein the non-circular cross-sections are selected from the group comprising: rectangular with rounded corners, rectangular with square corners, and ovoid.

14. The device of claim 10 , wherein the subset of wires composed of the platinum-tungsten alloy have a greater ultimate tensile strength, a greater Young's modulus, and a lesser magnetic susceptibility, respectively, than substantially identically dimensioned alternative wires composed of an alternative platinum-tungsten alloy having a percentage of tungsten that is about 8% by weight.

15. An implantable occlusive device, comprising:

a wire composed of a platinum-tungsten alloy, wherein the percentage of tungsten in the platinum-tungsten alloy is equal to or greater than about 16% by weight, and wherein the wire is wound into an elongate helical coil.

16. The device of claim 15 , wherein the helical coil is treated to assume a three-dimensional secondary shape when unconstrained.

17. The device of claim 16 , wherein the secondary shape is substantially spherical.

18. The device of claim 16 , wherein in the secondary shape, the coil has non-overlapping loops.

19. The device of claim 15 , wherein the wire is a drawn-filled tube.

20. The device of claim 15 , wherein the wire has a diameter in a range from about 0.0005″ (0.0127 mm) to about 0.005″ (0.127 mm), and wherein the coil has a primary wind diameter in a range from about 0.003″ (0.0762 mm) to about 0.030″ (0.762 mm).

21. The device of claim 15 , wherein the wire has a greater ultimate tensile strength, a greater Young's modulus, and a lesser magnetic susceptibility, respectively, than substantially identically dimensioned alternative wire wound into a coil and composed of an alternative platinum-tungsten alloy having a percentage of tungsten that is about 8% by weight.

Assignments (2)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2019
From: CHEN, HANCUN; LEE, ANDREW S.
To: STRYKER CORPORATION; STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 050689/0313 →